LakeShore Biopharma Statistics
Total Valuation
LSB has a market cap or net worth of $32.91 million. The enterprise value is $57.58 million.
Important Dates
The last earnings date was Thursday, December 19, 2024, before market open.
| Earnings Date | Dec 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LSB has 19.08 million shares outstanding.
| Current Share Class | 19.08M |
| Shares Outstanding | 19.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.12% |
| Owned by Institutions (%) | 4.47% |
| Float | 3.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| Forward PS | 0.04 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.13 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.08 |
Financial Efficiency
Return on equity (ROE) is -65.99% and return on invested capital (ROIC) is -20.01%.
| Return on Equity (ROE) | -65.99% |
| Return on Assets (ROA) | -13.85% |
| Return on Invested Capital (ROIC) | -20.01% |
| Return on Capital Employed (ROCE) | -50.38% |
| Revenue Per Employee | $104,770 |
| Profits Per Employee | -$79,199 |
| Employee Count | 758 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.94 |
Taxes
| Income Tax | -3.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.02% in the last 52 weeks. The beta is 0.59, so LSB's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +96.02% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 33.06 |
| Average Volume (20 Days) | 25,242 |
Short Selling Information
The latest short interest is 7,234, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 7,234 |
| Short Previous Month | 7,325 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.20% |
| Short Ratio (days to cover) | 1.07 |
Income Statement
In the last 12 months, LSB had revenue of $79.42 million and -$60.03 million in losses. Loss per share was -$5.61.
| Revenue | 79.42M |
| Gross Profit | 53.47M |
| Operating Income | -49.59M |
| Pretax Income | n/a |
| Net Income | -60.03M |
| EBITDA | -43.75M |
| EBIT | -49.59M |
| Loss Per Share | -$5.61 |
Full Income StatementBalance Sheet
The company has $34.12 million in cash and $58.79 million in debt, giving a net cash position of -$24.67 million or -$1.29 per share.
| Cash & Cash Equivalents | 34.12M |
| Total Debt | 58.79M |
| Net Cash | -24.67M |
| Net Cash Per Share | -$1.29 |
| Equity (Book Value) | 81.05M |
| Book Value Per Share | 4.26 |
| Working Capital | 13.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.89 million and capital expenditures -$6.13 million, giving a free cash flow of -$46.19 million.
| Operating Cash Flow | -40.89M |
| Capital Expenditures | -6.13M |
| Free Cash Flow | -46.19M |
| FCF Per Share | -$2.42 |
Full Cash Flow StatementMargins
Gross margin is 67.33%, with operating and profit margins of -62.45% and -75.59%.
| Gross Margin | 67.33% |
| Operating Margin | -62.45% |
| Pretax Margin | -79.38% |
| Profit Margin | -75.59% |
| EBITDA Margin | -55.09% |
| EBIT Margin | -62.45% |
| FCF Margin | n/a |